Evidence map›Paper›PMID 32504576›Full record

ReviewThe lancet. HIV2020

HIV outbreaks among people who inject drugs in Europe, North America, and Israel.

Don C Des Jarlais, Vana Sypsa, Jonathan Feelemyer, Adrian O Abagiu, Vic Arendt, Dita Broz, Daniel Chemtob, Carole Seguin-Devaux, Joan M Duwve, Margaret Fitzgerald and 10 more

Open access · greenAbstract readReview
In one paragraph

Review in The lancet. HIV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 5 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 5 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Review
  9. Article
  10. Infectious Diseases in People Who Use Drugs Introduction.Open forum infectious diseases · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 9 countries.

Don C Des JarlaisCollege of Global Public Health, New York University, New York, NY, USA. Electronic address: don.desjarlais@nyu.edu.
Vana SypsaDepartment of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Athens, Greece.
Jonathan FeelemyerCollege of Global Public Health, New York University, New York, NY, USA.
Adrian O AbagiuNational Institute for Infectious Diseases, Bucharest, Romania.
Vic ArendtService National des Maladies Infectieuses, Centre Hospitalier de Luxembourg, Luxembourg, USA.
Dita BrozCenters for Disease Control and Prevention, Atlanta, GA, USA.
Daniel ChemtobDepartment of Tuberculosis and AIDS, Ministry of Health, Jerusalem, Israel; Faculty of Medicine, Hebrew University-Hadassah Medical School, Braun School of Public Health and Community Medicine, Jerusalem, Israel.
Carole Seguin-DevauxDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch sur Alzette, Luxembourg.
Joan M DuwveRichard M Fairbanks School of Public Health, Indianapolis, IN, USA.
Margaret FitzgeraldHealth Services Executive, Dublin, Ireland.
David J GoldbergNHS National Services Scotland, Glasgow, UK.
Angelos HatzakisDepartment of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Athens, Greece; NHS National Services Scotland, Glasgow, UK.
Raluca E JipaNational Institute for Infectious Diseases, Bucharest, Romania.
Eugene KatchmanInfectious Diseases Unit, Tel Aviv Sourasky Medical Centre and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eamon KeenanHealth Services Executive, Dublin, Ireland.
Ibrahim KhanFirst Nations and Inuit Health Branch, Indigenous Services Canada, Regina, SK, Canada.
Stephanie KonradFirst Nations and Inuit Health Branch, Indigenous Services Canada, Regina, SK, Canada.
Andrew McAuleyNHS National Services Scotland, Glasgow, UK; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
Stuart SkinnerCollege of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Lucas WiessingEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
Health Service Executive · IENational and Kapodistrian University of Athens · GRNational Institute of Research and Development for Biological Sciences · ROCenters for Disease Control and Prevention · USCentre Hospitalier de Luxembourg · LUEuropean Monitoring Centre for Drugs and Drug Addiction · PTGlasgow Caledonian University · GBIndigenous Services CanadaInuit Tapiriit Kanatami · CAIsrael Ministry of Health · ILLuxembourg Institute of Health · LUNational Health Service Scotland · GBNew York College of Health Professions · USNew York University · USRichard M. Fairbanks Foundation · USTel Aviv University · ILUniversity of Saskatchewan · CA

Funding

Risk Factors for HIV/AIDS in Drug UsersR01DA003574 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C, MCKNIGHT, COURTNEY · 1986 to 2025
$16.2M
NIDA NIH HHS R01 DA003574
6 · The paper itself

Abstract

During 2011-16, HIV outbreaks occurred among people who inject drugs (PWID) in Canada (southeastern Saskatchewan), Greece (Athens), Ireland (Dublin), Israel (Tel Aviv), Luxembourg, Romania (Bucharest), Scotland (Glasgow), and USA (Scott County, Indiana). Factors common to many of these outbreaks included community economic problems, homelessness, and changes in drug injection patterns. The outbreaks differed in size (from under 100 to over 1000 newly reported HIV cases among PWID) and in the extent to which combined prevention had been implemented before, during, and after the outbreaks. Countries need to ensure high coverage of HIV prevention services and coverage higher than the current UNAIDS recommendation might be needed in areas in which short acting drugs are injected. In addition, monitoring of PWID with special attention for changing drug use patterns, risk behaviours, and susceptible subgroups (eg, PWID experiencing homelessness) needs to be in place to prevent or rapidly detect and contain new HIV outbreaks.

Indexed as

Disease OutbreaksEuropeFemaleHealth Services AccessibilityHIV InfectionsHumansIll-Housed PersonsIsraelMaleNorth AmericaSocioeconomic FactorsSubstance Abuse, Intravenous

Identifiers

PMID32504576
PMCPMC10150936
OpenAlexW3033175615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.